Biosimilar Monoclonal Antibody Market Sees Expanding Applications...

Ajouter une nouvelle offre d'emploi Autre

2026-05-28 06:35:37 - Traduire -

The global biosimilar monoclonal antibody market is witnessing remarkable growth due to the increasing demand for cost-effective biologic therapies and the growing burden of chronic diseases worldwide. The market was valued at USD 10.71 billion in 2024 and is projected to grow from USD 12.44 billion in 2025 to USD 40.77 billion by 2032, exhibiting a strong compound annual...

0 Commentaires 0 Parts 96 Vue 0 Aperçu